-
Gilead's Biktarvy wins megablockbuster HIV nod
fiercepharma
February 09, 2018
and rival GlaxoSmithKline strikes back...
-
NIH begins large HIV treatment study in pregnant women
europeanpharmaceuticalreview
January 25, 2018
Clinical trial will compare three antiretroviral drug regimens…
-
FDA approves Ortho’s HIV diagnostic test
biospectrumasia
December 25, 2017
The test is designed to identify HIV-1 and HIV-2 antibodies (Ab).
-
FIT Biotech granted U.S. patent for treating HIV
biospectrumasia
December 05, 2017
FIT Biotech granted U.S. patent for treating HIV The patent grants the Company exclusive rights to exploit its GTU®-based DNA vaccines, including FIT-06, for the treatment of HIV patients.
-
ViiV trials drug for HIV prevention in women
pharmatimes
December 01, 2017
ViiV Healthcare has initiated a Phase III study exploring the efficacy of long-acting cabotegravir for the prevention of HIV infection in sexually active women.
-
Health official receives recognition in Taiwan, China for HIV prevention
biospectrumasia
November 21, 2017
Taiwan, China's Centers for Disease Control launched a simple HIV saliva test program in September last year.
-
Scientists find where HIV 'hides' to evade detection by the immune system
worldpharmanews
October 20, 2017
In a decades-long game of hide and seek, scientists from Sydney's Westmead Institute for Medical Research have confi
-
Chemistry provides a new supply of a promising cancer and HIV treatment
worldpharmanews
October 16, 2017
A drug isolated from a marine pest holds promise for treating some of the world's nastiest diseases, and researchers would love to find out just how effective it is
-
Janssen’s HIV combo pill hits safety, efficacy targets
pharmatimes
October 10, 2017
Janssen Pharmaceutica’s experimental combination therapy for HIV containing four medicines in a single pill has hit safety and efficacy targets in a late stage trial, results of which have been published in The Lancet HIV.
-
Janssen submits new drug application to FDA for HIV-1 treatment
pharmaasia
September 30, 2017
The new drug that Janssen is seeking approval for would be the world’s first darunavir-based single tablet regimen for HIV-1.